Previous close | 7.91 |
Open | 7.89 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1000 |
Day's range | 7.30 - 7.91 |
52-week range | 6.31 - 15.25 |
Volume | |
Avg. volume | 50,371 |
Market cap | 126.096M |
Beta (5Y monthly) | -0.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.18 |
Earnings date | 10 Nov 2022 - 14 Nov 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 24 May 2022 |
1y target est | 15.50 |
Investors need to pay close attention to ProPhase Labs (PRPH) stock based on the movements in the options market lately.
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -60% and 28.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.